 Connection
David Morrison to Risk Factors
This is a "connection" page, showing publications David Morrison has written about Risk Factors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.060 |
|
|
|
-
Freedman SF, Beck AD, Nizam A, Vanderveen DK, Plager DA, Morrison DG, Drews-Botsch CD, Lambert SR. Glaucoma-Related Adverse Events at 10 Years in the Infant Aphakia Treatment Study: A Secondary Analysis of a Randomized Clinical Trial. JAMA Ophthalmol. 2021 02 01; 139(2):165-173.
Score: 0.015
-
Binenbaum G, Tomlinson LA, de Alba Campomanes AG, Bell EF, Donohue P, Morrison D, Quinn GE, Repka MX, Rogers D, Yang MB, Yu Y, Ying GS. Validation of the Postnatal Growth and Retinopathy of Prematurity Screening Criteria. JAMA Ophthalmol. 2020 01 01; 138(1):31-37.
Score: 0.014
-
Quinn GE, Ying GS, Bell EF, Donohue PK, Morrison D, Tomlinson LA, Binenbaum G. Incidence and Early Course of Retinopathy of Prematurity: Secondary Analysis of the Postnatal Growth and Retinopathy of Prematurity (G-ROP) Study. JAMA Ophthalmol. 2018 12 01; 136(12):1383-1389.
Score: 0.013
-
Cao JH, Wagner BD, Cerda A, McCourt EA, Palestine A, Enzenauer RW, Braverman RS, Wong RK, Tsui I, Gore C, Robbins SL, Puente MA, Kauffman L, Kong L, Morrison DG, Lynch AM. Colorado retinopathy of prematurity model: a multi-institutional validation study. J AAPOS. 2016 06; 20(3):220-5.
Score: 0.011
-
Colburn JD, Morrison DG, Estes RL, Li C, Lu P, Donahue SP. Longitudinal follow-up of hypermetropic children identified during preschool vision screening. J AAPOS. 2010 Jun; 14(3):211-5.
Score: 0.007
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|